Currently, research efforts aimed at inhibiting HIF-1α activity and its related pathways are predominantly concentrated in the oncology domain, with a notable deficiency in studies pertaining to renal diseases, particularly DKD. The gene discussed is HIF1A; the disease is kidney disorder.